Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Calling a special meeting

<< Previous

Bullboard Posts

Next >>

Comment by Bucknelly21on Sep 28, 2021 9:17am

106 Views

Post# 33929699

RE:RE:RE:RE:RE:Calling a special meeting

Palinc, I'm curious if you had to give Paul a grade right now for the time he's been there what would it be?

be quote=palinc2000]

What would you want to make
Clear?

jeffm34 wrote:

I think given their track record there is cause for concern. If I were a major shareholder, I would want to make my views very clear to management at this point.

palinc2000 wrote:

I respectfully disagree 100%....Waste of time and energy and money